Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Moclobemide
Drug ID BADD_D01483
Description A reversible monoamine oxidase inhibitor (MAOI) selective for isoform A (RIMA) used to treat major depressive disorder. Most meta-analyses and most studies indicate that in the acute management of depression, moclobemide is more efficacious than placebo medication and similarly efficacious as tricyclic antidepressants (TCA) or selective serotonin reuptake inhibitors (SSRIs). Due to negligible anticholinergic and antihistaminic actions, moclobemide has been better tolerated than tri- or heterocyclic antidepressants [A3901].
Indications and Usage For the treatment of major depressive disorder and bipolar disorder [A31901].
Marketing Status Not Available
ATC Code N06AG02
DrugBank ID DB01171
KEGG ID D02561
MeSH ID D020912
PubChem ID 4235
TTD Drug ID D01ZSO
NDC Product Code Not Available
Synonyms Moclobemide | Moclobamide | Apo-Moclobemide | Apo Moclobemide | Arima | Aurorix | Manerix | Moclamine | Aurorex | Chem mart Moclobemide | Moclobemide, Chem mart | DBL Moclobemide | Moclobemide, DBL | Deprenorm | Feraken | GenRX Moclobemide | Moclobemide, GenRX | Healthsense Moclobemide | Moclobemide, Healthsense | Moclix | Terry White Chemists Moclobemide | Moclobemid Stada | Stada, Moclobemid | Moclobemid von ct | von ct, Moclobemid | Moclobemid-1A Pharma | Moclobemid 1A Pharma | Moclobemid1A Pharma | Moclobemid-Puren | Moclobemid Puren | Moclobemid-ratiopharm | Moclobemid ratiopharm | Moclobeta | Moclodura | Moclonorm | Nu-Moclobemide | Nu Moclobemide | NuMoclobemide | PMS-Moclobemide | PMS Moclobemide | Rimoc | Ro 11-1163 | Ro 11 1163 | Ro-11-1163 | Novo-Moclobemide | Novo Moclobemide | NovoMoclobemide | Moclobemid AZU | AZU, Moclobemid
Chemical Information
Molecular Formula C13H17ClN2O2
CAS Registry Number 71320-77-9
SMILES C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal distension07.01.04.001--
Abdominal pain07.01.05.002--
Aggression19.05.01.001--Not Available
Agitation19.06.02.001; 17.02.05.012--
Angina pectoris24.04.04.002; 02.02.02.002--
Anxiety19.06.02.002--
Apathy19.04.04.002--Not Available
Asthenia08.01.01.001--Not Available
Bradycardia02.03.02.002--Not Available
Chest pain22.02.08.003; 08.01.08.002; 02.02.02.011--Not Available
Confusional state19.13.01.001; 17.02.03.005--
Conjunctivitis06.04.01.002; 11.01.06.012--
Constipation07.02.02.001--
Delusion19.10.01.001--
Dermatitis23.03.04.002--Not Available
Dermatitis allergic23.03.04.003; 10.01.03.014--Not Available
Dermatitis atopic23.03.04.016; 10.01.04.004--Not Available
Diarrhoea07.02.01.001--
Discomfort08.01.08.003--Not Available
Disorientation19.13.01.002; 17.02.05.015--Not Available
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Dry mouth07.06.01.002--
Dry skin23.03.03.001--
Dysarthria19.19.03.001; 17.02.08.001--
Dysgeusia17.02.07.003; 07.14.03.001--
Dyspepsia07.01.02.001--
Dyspnoea02.01.03.002; 22.02.01.004--
Dysuria20.02.02.002--
Extrasystoles02.03.02.003--Not Available
Fatigue08.01.01.002--
The 1th Page    1 2 3    Next   Last    Total 3 Pages